UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS Medical Dialogues Bureau29 Jan 2020 12:38 PM ISTThe National Institute for Health and Care Excellence (NICE), which determines if a drug is included in Britain's National Healthcare System (NHS),...
J&J CEO Alex Gorsky to testify at trial for first time on Baby Powder risks MD bureau28 Jan 2020 2:09 PM ISTNew Brunswick: Johnson & Johnson Chief Executive Officer Alex Gorsky was set to be called as a witness on Monday in what would be his first...
Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint Medical Dialogues Bureau24 Jan 2020 2:02 PM ISTUS: Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer...
JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth Medical Dialogues Bureau19 Jan 2020 10:00 AM ISTMumbai: Johnson & Johnson Services Inc. has announced its collaboration with the internationally acclaimed social change organization The MTV...
Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict Medical Dialogues Bureau18 Jan 2020 12:17 PM ISTNew York: A Pennsylvania court on Friday slashed a USD 8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury...
New tests shows NO sign of asbestos in recalled JnJ baby powder Medical Dialogues Bureau30 Oct 2019 1:18 PM ISTBut Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda Medical Dialogues Bureau9 Oct 2019 4:24 PM ISTJohnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 9:30 AM ISTNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Oklahoma judge to rule in opioid lawsuit against JnJ Medical Dialogues Bureau24 Aug 2019 9:10 AM ISTLawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
Canada enacts drug price crackdown, in blow to pharmaceutical industry Medical Dialogues Bureau11 Aug 2019 9:00 AM ISTThe changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
Oklahoma judge denies motion to end case against drugmaker JnJ Medical Dialogues Bureau9 July 2019 9:00 AM ISTDistrict Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
